Fact-checked by Grok 2 weeks ago

Thymidine triphosphate

Thymidine triphosphate, commonly abbreviated as dTTP or TTP, is a deoxyribonucleoside triphosphate that serves as one of the four fundamental building blocks for DNA synthesis in cells. It consists of the pyrimidine nucleobase thymine linked to a deoxyribose sugar molecule via a β-N1-glycosidic bond, with a triphosphate group esterified at the 5' carbon of the sugar. This molecule is essential for the replication and repair of genetic material, acting as a substrate for DNA polymerases that incorporate it into growing DNA strands opposite adenine bases. In biochemical pathways, dTTP is synthesized intracellularly from deoxythymidine monophosphate (dTMP) through sequential by thymidylate kinase and , providing the primary source of thymidine nucleotides for DNA production. Beyond its direct role in polymerization, dTTP functions as an allosteric regulator in nucleotide metabolism, influencing the balance between ribonucleotides and deoxyribonucleotides by modulating enzymes such as . The molecule's is C₁₀H₁₇N₂O₁₄P₃ (free acid form), with a molecular weight of approximately 482.2 g/mol, and it is highly soluble in aqueous solutions due to its charged phosphate groups. dTTP's importance extends to research and therapeutic applications, where imbalances in its levels are linked to mitochondrial disorders treatable via nucleoside supplementation, and it is targeted by antimetabolites like 5-fluorouracil in anticancer therapies to disrupt DNA synthesis in proliferating cells. In molecular biology techniques such as polymerase chain reaction (PCR), exogenous dTTP is supplied to enable efficient amplification of DNA sequences.

Overview

Definition and nomenclature

Thymidine triphosphate, commonly abbreviated as dTTP, is a deoxyribonucleoside triphosphate consisting of the base , the , and a chain of three groups attached to the 5' carbon of the . This serves as one of the fundamental building blocks for , distinguishing it from ribonucleotides such as triphosphate (UTP), which features a and uracil base instead. The systematic IUPAC name for dTTP is [(2R,3S,5R)-5-(2,4-dioxo-3,4-dihydro-5-methylpyrimidin-1(2H)-yl)-3-hydroxyoxolan-2-yl]methyl triphosphate, reflecting its and the triphosphate linkage. Common synonyms include 5'-triphosphate and deoxythymidine triphosphate, with "deoxy" specifying the absence of a hydroxyl group at the 2' position of the , a key feature that differentiates deoxyribonucleotides from their counterparts. The "triphosphate" designation highlights the three groups connected via high-energy phosphoanhydride bonds, which provide the energy required for during synthesis. dTTP is classified as one of the four canonical deoxyribonucleoside triphosphates (dNTPs)—alongside deoxyadenosine triphosphate (dATP), deoxycytidine triphosphate (dCTP), and deoxyguanosine triphosphate (dGTP)—that are essential substrates for DNA polymerases in cellular replication processes. This classification underscores its role within the deoxyribonucleotide family, which is specific to DNA and excludes ribonucleoside triphosphates (NTPs) used in RNA synthesis. The nomenclature of dTTP derives from thymine, the pyrimidine base first isolated from DNA in 1893 by Albrecht Kossel, who named it after the thymus gland where it was abundant. "Thymidine" refers to the corresponding nucleoside (thymine linked to deoxyribose). Kossel's work laid the foundation for nucleotide naming conventions, with subsequent additions like "triphosphate" adopted in the mid-20th century to describe the phosphorylated forms as elucidated by biochemists such as Arthur Kornberg in studies on DNA replication.

Biological significance

Thymidine triphosphate (dTTP) plays a central role in DNA synthesis as the exclusive precursor for incorporating thymine bases, which pair specifically with adenine in double-stranded DNA. This base pairing is mediated by two hydrogen bonds between the thymine and adenine residues, ensuring structural stability and high fidelity during replication and transcription processes. The specificity of dTTP to DNA, rather than RNA, underscores its importance in maintaining the integrity of the genetic code, as deviations in pairing could lead to mismatches and genomic errors. The evolutionary adoption of thymine in DNA, in place of uracil used in RNA, represents a key adaptation to mitigate spontaneous mutations arising from cytosine deamination. Cytosine naturally deaminates to uracil at a significant rate—estimated at hundreds of events per human genome per day—potentially causing C-to-U (and thus C-to-T) transitions if unrepaired. By employing thymine (5-methyluracil) as the standard base, DNA enables cells to detect uracil as aberrant (from deamination) and excise it via uracil-DNA glycosylase, preventing its pairing with adenine and thereby reducing the overall mutation rate by orders of magnitude compared to a uracil-based system. This distinction enhances genomic stability over evolutionary timescales. In cellular environments, dTTP concentrations are precisely regulated at micromolar levels, typically 5–50 μM in mammalian cells, to support balanced while avoiding pool imbalances that could promote or replication . Although dTTP often constitutes a major fraction of the total dNTP pool in proliferating cells, its levels are kept relatively low compared to ribonucleotide triphosphates (in the millimolar range) to fine-tune incorporation rates and prevent excessive thymine bias. Depletion of dTTP, such as through inhibition of its biosynthetic pathways, directly halts activity due to substrate limitation, triggering S-phase arrest and activation of DNA damage checkpoints to avert catastrophic genomic instability.

Chemical properties

Molecular structure

Thymidine triphosphate (dTTP) is composed of a base, a sugar, and a triphosphate moiety. The base, a derivative, features a six-membered heterocyclic with atoms at positions 1 and 3, carbonyl groups at C2 and C4, and a distinctive attached to , distinguishing it from uracil. This base is covalently linked to the C1' anomeric carbon of the β-D-2-deoxyribofuranose through an N1-glycosidic (β-N-glycosidic) bond. The adopts a conformation and lacks a hydroxyl group at the 2' position, while retaining a free hydroxyl at the 3' position, which enables subsequent formation during DNA . The triphosphate group is esterified to the 5'-hydroxyl of the via a phosphoester bond to the α-phosphate. The triphosphate chain comprises three phosphate units (α, β, and γ) interconnected by high-energy phosphoanhydride linkages between the α-β and β-γ phosphates, with terminal hydroxyl groups on the α- and γ-phosphates that can ionize under physiological conditions. This arrangement provides the energy required for nucleotide incorporation into growing DNA strands. The overall connectivity forms a linear chain: thymine—N1—C1'(sugar)—C5'—O—Pα—O—Pβ—O—Pγ, where the sugar ring links C1' to C4' with C5' as the exocyclic methylene bearing the triphosphate. The stereochemistry of dTTP is defined by three chiral centers in the deoxyribose sugar, exhibiting the (2R,3S,5R)-configuration in the tetrahydrofuran (oxolane) ring numbering, consistent with the natural β-D series. This includes the β-orientation at C1' for the glycosidic bond and specific hydroxyl orientations at C3' and C4'. In aqueous solution, the molecule predominantly adopts an anti conformation around the N-glycosidic bond (χ torsion angle ≈ 180°), positioning the base away from the sugar, which favors its role in base pairing. Unlike deoxyuridine triphosphate (dUTP), which bears an unmodified uracil base, the 5-methyl substituent on thymine in dTTP sterically and electronically modulates base recognition, aiding enzymes in distinguishing it from uracil to prevent erroneous incorporation during DNA synthesis. The standard structural representation of dTTP can be depicted textually as:
[Thymine](/page/Thymine) (5-methyl-2,4-dioxopyrimidin-1-yl) - β-N1 - [2-deoxy-β-D-ribofuranose] - 5'-O - P(=O)(OH)-O-P(=O)(OH)-O-P(=O)(OH)₂
with the sugar ring showing C2'—H₂ and C3'—OH.

Physical and chemical characteristics

The free acid form of thymidine triphosphate (dTTP) has a of 482.17 g/ and an of C₁₀H₁₇N₂O₁₄P₃; the common sodium appears as a white to off-white crystalline solid with adjusted mass (e.g., 504.15 g/ for the mono-sodium ). The sodium form exhibits high solubility in , with commercial solutions up to 100 (~55 mg/mL at neutral ). dTTP displays a characteristic UV absorbance maximum at 267 nm, arising from the conjugated π-system of the base. Chemically, dTTP demonstrates stability under neutral conditions but hydrolyzes in acidic environments (pH <4) to yield thymidine monophosphate, with the triphosphate chain cleaving preferentially at the anhydride bonds. It is susceptible to enzymatic dephosphorylation by alkaline phosphatase, which sequentially removes the γ-, β-, and α-phosphates. The γ-phosphate serves as a high-energy group, enabling nucleotidyl transfer reactions through cleavage of the β-γ phosphoanhydride bond. The strongest acidic pKa for its phosphate groups is approximately 0.9, while the thymine N3-H proton has a pKa of ~9.8, influencing its ionization state at physiological pH. In terms of reactivity, the α-phosphate undergoes nucleophilic attack by the 3'-hydroxyl of growing DNA chains during polymerization, a process that requires coordination with divalent cations like Mg²⁺ to form a reactive complex and neutralize phosphate charges.

Biosynthesis

De novo pathway

The de novo biosynthesis of thymidine triphosphate (dTTP) initiates with the reduction of uridine diphosphate (UDP) to deoxyuridine diphosphate (dUDP) by the enzyme ribonucleotide reductase (RNR). dUDP is then phosphorylated to deoxyuridine triphosphate (dUTP) by nucleoside diphosphate kinase, and dUTP is hydrolyzed to deoxyuridine monophosphate (dUMP) by dUTP pyrophosphatase. Alternatively, dUMP can be produced via the deoxycytidine pathway, where cytidine diphosphate (CDP) is reduced to deoxycytidine diphosphate (dCDP) by RNR, dephosphorylated to deoxycytidine monophosphate (dCMP), and deaminated to dUMP by dCMP deaminase. These steps convert ribonucleotides to their deoxyribonucleotide counterparts, providing the foundational precursor for thymine nucleotide synthesis independent of exogenous sources. The pivotal reaction in this pathway is catalyzed by thymidylate synthase (TYMS), which methylates dUMP to produce deoxythymidine monophosphate (dTMP). TYMS utilizes 5,10-methylenetetrahydrofolate (CH₂-THF) as the methyl donor, transferring a methylene group and reducing it to dihydrofolate (DHF) in the process. The reaction can be represented as: \text{dUMP} + \text{CH}_2\text{-THF} \to \text{dTMP} + \text{DHF} To sustain the pathway, DHF is subsequently reduced back to tetrahydrofolate (THF) by dihydrofolate reductase (DHFR), regenerating the cofactor with NADPH as the electron donor and enabling continuous cycles of methylation. This folate-dependent step is essential for providing the thymine base required for DNA synthesis. Following dTMP formation, sequential phosphorylation converts it to dTTP. Thymidylate kinase (TMPK, also known as DTYMK) first dTMP to deoxythymidine diphosphate (dTDP) using ATP as the donor. Then, (NDPK) further dTDP to dTTP, again utilizing ATP or other nucleoside triphosphates. These steps ensure the accumulation of the triphosphate form necessary for activity. Regulation of the de novo pathway is primarily exerted at the TYMS level, with enzyme activity and expression being cell cycle-dependent and upregulated during the S-phase to meet the demands of DNA replication. TYMS is also a target for inhibition by antifolates, such as methotrexate, which block DHFR and deplete the folate cofactor, or fluoropyrimidines like 5-fluorouracil that form a covalent complex with TYMS, thereby halting dTMP production.

Salvage pathway

The salvage pathway recycles free thymidine into deoxythymidine triphosphate (dTTP), serving as an efficient route for nucleotide replenishment, especially during periods of high demand in proliferating cells. Free thymidine originates from dietary sources or the degradation of DNA and is transported into the cytosol via equilibrative nucleoside transporters, such as ENT1, which facilitate passive diffusion across the cell membrane. The pathway initiates with the of to deoxythymidine monophosphate (dTMP) by the cytosolic enzyme 1 (TK1), which is specifically induced during the S-phase of the to meet replication needs. TK1 activity is tightly regulated, with levels peaking in proliferating cells and degrading post-S-phase via the ubiquitin-proteasome pathway. Subsequent convert dTMP to dTDP via thymidylate kinase and then dTDP to dTTP via (NDPK), all utilizing ATP as the phosphate donor. These reactions are summarized as follows: \text{Thymidine} + \text{ATP} \xrightarrow{\text{TK1}} \text{dTMP} + \text{[ADP](/page/ADP)} \text{dTMP} + \text{ATP} \xrightarrow{\text{dTMP kinase}} \text{dTDP} + \text{[ADP](/page/ADP)} \text{dTDP} + \text{ATP} \xrightarrow{\text{NDPK}} \text{dTTP} + \text{[ADP](/page/ADP)} This salvage route bypasses the folate-dependent methylation of dUMP to dTMP in the pathway, providing a less energetically demanding alternative that recycles preformed nucleosides for rapid dTTP production. In proliferating cells, the salvage pathway acts as a major contributor to dTTP pools, supporting and repair demands.

Biological functions

Role in DNA replication

Thymidine triphosphate (dTTP) serves as a critical substrate in , providing the deoxythymidine monophosphate (dTMP) residue for incorporation into the growing DNA strand opposite bases in the template. In eukaryotic cells, this incorporation is primarily catalyzed by replicative DNA polymerases δ and ε, which extend the primer-template complex during semi-conservative replication at the replication fork. The mechanistic process involves the 3'-hydroxyl group of the terminal nucleotide in the growing DNA chain performing a nucleophilic attack on the α-phosphate of the incoming dTTP molecule, forming a new and releasing inorganic (PPi). This reaction can be represented as: (\ce{DNA})_n - 3'\ce{-OH} + \ce{dTTP} \rightarrow (\ce{DNA})_{n+1} - 3'\ce{-O-dTMP} + \ce{PPi} The fidelity of this incorporation is enhanced by the proofreading activity of the 3'→5' exonuclease domain in DNA polymerases δ and ε, which excises misincorporated dTMP residues if base-pairing errors occur. Additionally, the cellular dTTP:dUTP ratio is tightly regulated to minimize uracil substitution for , as dUTPase hydrolyzes dUTP to prevent its incorporation by DNA polymerase, thereby maintaining replication accuracy. dTTP levels are dynamically regulated during the , peaking in S-phase to meet the demands of and support efficient semi-conservative replication. In synchronized mammalian cells, dTTP pools expand up to 20-fold from G0 to S-phase, ensuring sufficient substrate availability for polymerases. Imbalances, such as excess dTTP, disrupt this homeostasis by allosterically inhibiting , leading to dCTP depletion and increased through biased nucleotide incorporation.

Involvement in DNA repair and other processes

Thymidine triphosphate (dTTP) serves as a critical substrate for DNA polymerases during the resynthesis step in various DNA repair pathways, enabling the replacement of damaged or excised nucleotides to restore genomic integrity. In base excision repair (BER), which addresses small base lesions such as oxidative damage or uracil misincorporation, dTTP is incorporated by DNA polymerase β (Polβ) to fill single-nucleotide gaps following glycosylase-mediated base removal and AP endonuclease incision; for instance, in the uracil-DNA glycosylase (UNG) pathway, dTTP replaces the excised uracil to prevent mutagenesis. Similarly, in nucleotide excision repair (NER), which removes bulky adducts like UV-induced cyclobutane pyrimidine dimers, dTTP supports polymerase-mediated gap filling after dual incisions by excision nucleases, ensuring accurate reconstruction of the 20-30 nucleotide patch. In mismatch repair (MMR), dTTP facilitates faithful resynthesis following excision of mismatched bases or insertion/deletion loops by Exo1, with polymerase δ or ε utilizing dTTP to synthesize the new strand complementary to the parental template. Following gap filling in these repair processes, seals the resulting nicks to complete the pathway, with dTTP indirectly contributing by providing the phosphodiester backbone for readiness; eukaryotic I, which predominates in BER, NER, and MMR, catalyzes this ATP-dependent joining without direct utilization of dTTP's phosphate for energy transfer. Beyond repair, elevated dTTP levels exert on (RNR), inhibiting the reduction of CDP and UDP to dCDP and dUDP while activating GDP reduction to maintain balanced deoxyribonucleotide triphosphate (dNTP) pools essential for DNA fidelity. In (mtDNA) maintenance, dTTP pools support replication and repair within the organelle, where deficiencies—such as those from 2 (TK2) mutations—lead to mtDNA depletion and impaired repair of oxidative lesions, highlighting dTTP's role in mitochondrial genome stability. Additionally, in viral contexts, dTTP acts as a substrate for retroviral reverse transcriptases, such as HIV-1 RT, during proviral from viral templates, where its incorporation is targeted by nucleoside analogs like AZT-triphosphate for therapeutic inhibition.

Regulation and metabolism

Cellular pool maintenance

The intracellular concentration of thymidine triphosphate (dTTP) is tightly regulated to support while preventing from imbalances. This maintenance involves feedback mechanisms, spatial compartmentalization, and checkpoint pathways that adjust synthesis rates in response to cellular needs, primarily drawing from and salvage biosynthetic pathways. Feedback regulation plays a central role in controlling dTTP levels. High dTTP concentrations allosterically bind to the specificity site of (RNR), inhibiting the reduction of CDP to dCDP to balance dNTP production, while promoting GDP reduction for dGTP synthesis.67152-8/fulltext) Additionally, dTTP acts as a competitive of 1 (TK1), the key in the salvage pathway that phosphorylates to dTMP, thereby limiting further dTTP accumulation with a Ki of approximately 7 μM.31547-3/pdf) dTTP pools are compartmentalized between the , where synthesis occurs, and the , where it is consumed during . Nuclear dTTP levels are typically higher than cytosolic ones, with total dNTP concentrations reaching about 300 μM in the compared to 90 μM in the in proliferating cells.42175-3/pdf) Transport across the occurs via passive through complexes, as dNTPs are small molecules below the size exclusion limit of approximately 40-60 . Checkpoint controls, particularly the DNA damage response, further modulate dTTP synthesis to ensure pool balance. In cases of replication stress or imbalance, ATR kinase activation inhibits excessive dNTP production by regulating RNR stability and activity, preventing further synthesis that could exacerbate mutagenesis. In non-proliferating cells, steady-state dTTP concentrations are maintained at approximately 5-10 μM, sufficient for DNA repair and mitochondrial maintenance. During S-phase, levels can increase up to 200 μM to meet replication demands, representing a 20-fold expansion from quiescent states. Imbalances in dTTP pools disrupt genomic stability. dTTP starvation, often from RNR inhibition, triggers replication fork stalling and activates apoptotic pathways via prolonged DNA damage signaling. Conversely, excess dTTP causes nucleotide imbalance, leading to replication stress, increased mutagenesis, and stalled forks due to mismatched dNTP ratios.

Degradation and homeostasis

Thymidine triphosphate (dTTP) undergoes stepwise as the initial phase of its catabolic breakdown, primarily catalyzed by deoxyribonucleotidases. Cytosolic 5'-deoxynucleotidase (cdN) and mitochondrial 5'-deoxynucleotidase (mdN) facilitate the conversion of dTTP to dTDP and inorganic (Pi), followed by dTDP to dTMP and Pi; these enzymes also dephosphorylate dTMP to . For example, the reaction dTTP + H₂O → dTDP + Pi exemplifies the phosphatase activity involved in this process. Additionally, SAMHD1, a dNTP triphosphohydrolase, directly hydrolyzes dTTP to dTMP and , contributing to pool regulation particularly in non-dividing cells. The resulting thymidine is further degraded by thymidine phosphorylase (TP), which cleaves it into and 2-deoxy-α-D-ribose-1-phosphate in the . then enters the catabolic pathway, where dihydropyrimidine (DPD) reduces it to 5,6-dihydrothymine, followed by ring-opening catalyzed by dihydropyrimidinase (DPYS) to form 5-carboxyureido-4-methylpentanoate or related intermediates, ultimately yielding β-aminoisobutyrate, CO₂, and NH₃. This sequential degradation ensures efficient breakdown of excess dTTP-derived components. Degradation pathways play a critical role in dTTP by preventing toxic accumulation of deoxyribonucleotides, which can lead to genomic instability through imbalanced or . maintains nucleotide equilibrium by limiting pool sizes and enabling base recycling through salvage pathways, such as reconversion of via . In cultured fibroblasts, the dTTP pool exhibits a of approximately 4-5 minutes during S-phase due to rapid turnover, extending to 15-30 minutes or longer in quiescent states, reflecting slower catabolic rates outside . Regulatory mechanisms modulate these catabolic enzymes to align with cellular demands; for instance, deoxyribonucleotidase and SAMHD1 activities are upregulated in quiescent cells to suppress dTTP levels and inhibit untimely , while they are relatively inhibited during proliferation when dominates. This dynamic control, including feedback from overall pools, ensures balanced across phases.

Medical and research applications

Therapeutic implications

Thymidine triphosphate (dTTP) plays a critical role in therapeutic strategies targeting , particularly in rapidly proliferating cells such as cancer and viral-infected cells. In , drugs like 5-fluorouracil (5-FU) inhibit (TYMS), leading to depletion of dTMP and subsequent reduction in dTTP pools, which induces a "thymineless " in S-phase-specific tumor cells by halting . Similarly, targets (DHFR), disrupting metabolism and indirectly impairing TYMS activity, resulting in dTTP depletion and inhibition of in malignant cells. These mechanisms exploit the high dTTP demand in proliferating cancer cells, making dTTP pathway inhibition a cornerstone of antimetabolite-based regimens for cancers like colorectal and . In antiviral therapy, nucleoside analogs such as (AZT) compete directly with dTTP for incorporation by HIV-1 , acting as chain terminators to block viral DNA synthesis. AZT's triphosphate form (AZT-TP) mimics dTTP with high affinity for the enzyme, preferentially integrating into nascent viral DNA and preventing elongation, which has established it as a key component in antiretroviral regimens despite resistance challenges. Diseases arising from dTTP imbalance highlight its therapeutic relevance beyond . Mutations in thymidine kinase 2 (TK2), which phosphorylates to support mitochondrial dTTP pools, cause TK2 deficiency—a manifesting as progressive myopathy and encephalomyopathy. This leads to insufficient dTTP for mtDNA maintenance, resulting in multisystem disorders. As of March 2025, the FDA-approved Kygevvi (deoxycytidine and deoxythymidine) targets the salvage pathway by providing nucleosides that are phosphorylated to increase dCTP and dTTP levels, thereby restoring mtDNA copy number and improving motor outcomes. Clinically, dTTP levels serve as a in management, with elevated pools in leukemic blasts correlating to proliferation rates and aiding in and monitoring response to therapy. In cancers overexpressing thymidine kinase 1 (TK1)—a key salvage —the pathway is targeted to exploit dependency on exogenous salvage, with TK1 inhibitors or imaging probes enhancing selective antitumor effects in high-TK1 tumors like . Emerging applications involve dTTP analogs to refine CRISPR-Cas9 editing precision. Thymidine analogs like azidothymidine modulate pathways; for instance, AZT enhances (NHEJ) efficiency by inhibiting (HDR), favoring gene knockouts and potentially reducing off-target insertions during .

Role in diagnostics and

Thymidine triphosphate (dTTP) plays a vital role in diagnostics through the measurement of cellular dNTP pools, which are frequently elevated in proliferative disorders such as cancer. High dTTP and overall dNTP levels correlate with increased tumor and contribute to genomic , serving as potential prognostic biomarkers for progression and therapeutic response. Techniques like (HPLC) and liquid chromatography-mass spectrometry (LC-MS/MS) enable precise quantification of dTTP in clinical samples, including tumor tissues and peripheral blood mononuclear cells from cancer patients, providing insights into disease aggressiveness without relying on invasive biopsies. In , dTTP is an essential constituent of () master mixes, where it supplies the thymine-building block for enzymatic during amplification cycles. Commercial formulations typically include balanced concentrations of all four dNTPs, including dTTP, alongside , Mg²⁺, and buffers to ensure robust and specific product yield in routine molecular assays. Labeled dTTP derivatives, such as biotin-conjugated analogs, facilitate detection in next-generation sequencing (NGS) workflows, particularly sequencing by synthesis platforms where reversible terminator nucleotides incorporate into growing strands for real-time base calling and library preparation. As a , dTTP structural analogs like bromodeoxyuridine (BrdU) enable tracking of in proliferating cells. In protocols, BrdU is incorporated into nascent DNA strands during the S-phase after intracellular to BrdUTP, allowing subsequent immunodetection or enzymatic labeling to quantify progression and proliferation rates in heterogeneous populations, such as tumor-derived samples. This approach provides quantitative metrics on S-phase fraction, aiding studies of dynamics without disrupting cellular architecture. dTTP supports specific in vitro applications, including DNA ligation kits for sticky-end cloning, where it acts as a substrate for DNA polymerase to fill in overhangs, generating blunt ends compatible with ligase-mediated joining. This step enhances cloning efficiency in vector-insert assembly, minimizing background self-ligation and enabling precise recombinant DNA construction. In synthetic biology, dTTP is integral to multi-fragment DNA assembly techniques, such as Gibson assembly, where it fuels exonuclease and polymerase activities to overlap and extend DNA parts into seamless constructs for engineering novel genetic circuits. Historically, dTTP's utility in traces back to the with the development of the method, which employed dTTP alongside dideoxythymidine triphosphate (ddTTP) to terminate chain elongation and produce readable DNA ladders via . This enzymatic approach revolutionized genomic analysis, laying the foundation for modern sequencing technologies.

References

  1. [1]
    Thymidine 5 -triphosphate = 96 18423-43-3
    ### Summary of Thymidine 5'-triphosphate (dTTP) from Sigma-Aldrich (T0251)
  2. [2]
  3. [3]
  4. [4]
  5. [5]
    Base Pair - National Human Genome Research Institute (NHGRI)
    The two strands are held together by hydrogen bonds between pairs of bases: adenine pairs with thymine, and cytosine pairs with guanine.
  6. [6]
    Instability and decay of the primary structure of DNA - Nature
    ### Summary of DNA Using Thymine Instead of Uracil (Related to Cytosine Deamination and Mutation Rates)
  7. [7]
    Keeping Uracil Out of DNA: Physiological Role, Structure and ...
    There are two ways for uracil to appear in DNA: thymine replacement and cytosine deamination. Most DNA polymerases readily incorporate dUMP as well as dTMP ...
  8. [8]
    Understanding the interplay between dNTP metabolism and ... - PMC
    From experiments with cultured cells, dNTP pools typically range from 10 to 100 µM, with pool sizes increasing 5- to 10-fold when cells proliferate and ...
  9. [9]
    Deoxyribonucleotides as genetic and metabolic regulators - PMC
    Although, as noted earlier, dGTP is almost invariably the least abundant component of the dNTP pool, typically representing ≤5 mol% of total dNTP, that ratio ...
  10. [10]
    A defective dNTP pool hinders DNA replication in cell cycle ... - NIH
    Feb 10, 2017 · The concentration ranges considered were 10–100 μM for TdR and 100–500 μM for GdR. The concentrations selected were the ones restoring myoblast- ...Missing: micromolar | Show results with:micromolar
  11. [11]
    dTTP
    Insufficient relevant content. The provided URL content from PubChem (https://pubchem.ncbi.nlm.nih.gov/compound/64968) does not include detailed molecular structure information for Thymidine triphosphate (dTTP). It only displays a PubChem logo, a JavaScript requirement notice, and a server busy error message. No structural details (e.g., thymine base, deoxyribose sugar, triphosphate, bonds, stereochemistry) or comparisons to dUTP are available.
  12. [12]
    TTP Ligand Summary Page - RCSB PDB
    Jul 8, 1999 · THYMIDINE-5'-TRIPHOSPHATE · [(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) ...
  13. [13]
    Thymidine-5'-Triphosphate, Sodium Salt CAS 18423-43-3|Free acid
    Water (KF). ≤10%. Appearance. White to off-white solid. Solubility (50mg/ml, water). Clear, colorless and complete. UV Content (dry basis). ≥90%. Melting Point.
  14. [14]
    2'-Deoxythymidine 5'-triphosphate [dTTP] trisodium salt - Abcam
    Solubility. Soluble in water to 75 mM. Biological description. Nucleoside triphosphate used in many molecular biology applications such as DNA sequencing, PCR ...
  15. [15]
    Synthesis and DNA‐Polymerase Incorporation of Colored 4 ...
    The UV spectrum of SeTTP (λmax=369 nm, ε=1.8×104 M−1 cm−1, yellow) reveals a larger absorption and a red shift of 100 nm relative to that of TTP (λmax=267 nm ...
  16. [16]
    dTTP | Bioline | Meridian Bioscience
    Meridian dTTP is supplied as lithium salts in purified water, as lithium salts have greater resistance to repeated freezing and thawing cycles than sodium salts ...
  17. [17]
    Showing metabocard for Thymidine 5'-triphosphate (HMDB0001342)
    Nov 16, 2005 · Thymidine 5'-triphosphate, also known as TTP or DTHD5'ppp, belongs to the class of organic compounds known as pyrimidine 2'-deoxyribonucleoside ...
  18. [18]
    Protonation/deprotonation energetics of uracil, thymine, and ...
    Aug 6, 2025 · We confirmed these prior findings by measuring the pK a s for the nucleotides [ 13 C, 15 N]-rUTP and [ 13 C, 15 N]-dTTP, using N3/C4 NMR ...
  19. [19]
    Coupling dTTP Hydrolysis with DNA Unwinding by the DNA ...
    Background: The T7 DNA helicase couples the hydrolysis of dTTP to translocation on ssDNA and the unwinding of dsDNA. Results: Phe523, positioned in a ...
  20. [20]
    7.12: Deoxyribonucleotide de novo Biosynthesis - Biology LibreTexts
    Aug 31, 2023 · Synthesis of deoxyribonucleotides de novo requires an interesting enzyme called ribonucleotide reductase (RNR).
  21. [21]
    Ribonucleotide Reductase - an overview | ScienceDirect Topics
    Alternatively, dUMP is derived from a cytosine nucleotide (Figure 3). In eukaryotes and classic Gram-positive bacteria belonging to the bacilli or streptococci ...
  22. [22]
    Identification of a de novo thymidylate biosynthesis pathway ... - PNAS
    Aug 26, 2011 · TYMS converts methyleneTHF and dUMP to dihydrofolate (DHF) and dTMP. DHF is converted to THF for subsequent rounds of dTMP synthesis in an NADPH ...
  23. [23]
  24. [24]
    DTYMK - Thymidylate kinase - Homo sapiens (Human) | UniProtKB
    Dec 7, 2004 · Catalyzes the phosphorylation of thymidine monophosphate (dTMP) to thymidine diphosphate (dTDP), the immediate precursor for the DNA building block dTTP.
  25. [25]
    Cell-cycle-directed regulation of thymidylate synthase messenger ...
    This is consistent with several studies showing that the acute induction of TS as cells enter S phase is controlled primarily at the translational level.
  26. [26]
    The role of thymidylate synthase induction in modulating p53 ...
    Thymidylate synthase (TS) is a critical target for chemotherapeutic agents such as 5-fluorouracil (5-FU) and antifolates such as tomudex (TDX),multitargeted ...
  27. [27]
    Thymidine kinase 1 through the ages: a comprehensive review
    Nov 27, 2020 · Successive enzymes within the cytosol then convert dTMP to its triphosphate form deoxythymidine triphosphate (dTTP) prior to DNA replication.<|control11|><|separator|>
  28. [28]
    TK1 - Thymidine kinase, cytosolic - Homo sapiens (Human) - UniProt
    Catalyzes the first enzymatic step in the salvage pathway converting thymidine into thymidine monophosphate (PubMed:22385435). Transcriptional regulation limits ...<|control11|><|separator|>
  29. [29]
    Nucleoside salvage pathway kinases regulate hematopoiesis by ...
    Nov 12, 2012 · We show that inactivation of dCK in mice depletes deoxycytidine triphosphate (dCTP) pools and induces RS, early S-phase arrest, and DNA damage ...
  30. [30]
    DNA polymerases divide the labor of genome replication - PMC - NIH
    These polymerases catalyze the formation of phosphodiester linkages between monomers via nucleophilic attack on the α-phosphate of an incoming dNTP by the 3´- ...
  31. [31]
    The high fidelity and unique error signature of human DNA ... - NIH
    Bulk replicative DNA synthesis in eukaryotes is highly accurate and efficient, primarily because of two DNA polymerases (Pols): Pols δ and ε.
  32. [32]
    DNA polymerase proofreading: active site switching catalyzed ... - NIH
    DNA polymerase proofreading removes misincorporated nucleotides at the primer-end (1,2), which significantly improves the fidelity of DNA replication (3).
  33. [33]
    Differential control of dNTP biosynthesis and genome integrity ... - NIH
    Jul 20, 2017 · In addition, the elimination of dUTP by these enzymes prevents harmful uracil incorporation into DNA. These two beneficial outcomes have ...
  34. [34]
    Deoxyuracil in DNA and Disease: Genomic Signal or ... - PMC - NIH
    Rates of uracil misincorporation into DNA is believed to be determined the dUTP:dTTP ratio. In vitro studies indicate that DNA polymerases incorporate both dTTP ...
  35. [35]
    Control of dTTP pool size by anaphase promoting complex ... - NIH
    After completion of DNA replication, dTTP synthesis is no longer in great demand during the G2/M phase, and cellular dTTP drops to a low level until the mid-G1 ...
  36. [36]
    A Critical Balance: dNTPs and the Maintenance of Genome Stability
    Jan 31, 2017 · This leads to an elevated level of dTTP in mitochondria, which is not deleterious in itself but leads to secondary dCTP depletion and ...
  37. [37]
    Highly mutagenic and severely imbalanced dNTP pools can escape ...
    Because dNTP pool imbalances are mutagenic, the concentration of dNTPs is tightly controlled (1,2). Most of dNTP pool imbalances are detected by the cell. An ...
  38. [38]
    Base Excision Repair - PMC - NIH
    Base excision repair (BER) corrects DNA damage from oxidation, deamination and alkylation. Such base lesions cause little distortion to the DNA helix structure.
  39. [39]
    Interlocking activities of DNA polymerase β in the base excision ...
    Mar 1, 2022 · Base excision repair (BER) is a major cellular pathway for DNA damage repair. During BER, DNA polymerase β (Polβ) is hypothesized to first ...
  40. [40]
    Accessibility of DNA polymerases to repair synthesis during ... - NIH
    Nucleotide excision repair (NER) removes a variety of DNA lesions. Using a yeast cell-free repair system, we have analyzed the repair synthesis step of NER.
  41. [41]
    Thymidylate kinase is critical for DNA repair via ATM-dependent ...
    Sep 10, 2018 · Cellular supply of deoxythymidine triphosphate (dTTP) is crucial for DNA replication and repair. Thymidylate kinase (TMPK) catalyzes the ...
  42. [42]
    Pol β gap filling, DNA ligation and substrate-product channeling ...
    The nicked products after pol β dGTP insertion can be ligated by DNA ligase I or DNA ligase III/XRCC1 complex when a 5mC oxidation modification is present ...
  43. [43]
    Allosteric Inhibition of Human Ribonucleotide Reductase by dATP ...
    Dec 21, 2015 · We present an X-ray crystal structure of the human α subunit in the presence of inhibiting levels of dATP, depicting a ring-shaped hexamer.
  44. [44]
    Defects in Maintenance of Mitochondrial DNA Are Associated With ...
    Jun 15, 2007 · Our result is consistent with a deficiency in the intramitochondrial pool of dTTP relative to dCTP in cells from patients with TK2 deficiency ...
  45. [45]
    Identification of the nucleotide binding site of HIV-1 reverse ...
    We have utilized UV-induced cross-linking of [methyl-3H]dTTP to identify the nucleotide binding site on heterodimeric HIV-1 reverse transcriptase (RT).
  46. [46]
    Deoxynucleoside triphosphate (dNTP) synthesis and destruction ...
    Depletion of SAMHD1 levels in cycling cells increased the dNTP concentration in non–S-phase cells and caused an arrest in the G1 phase.
  47. [47]
    The Transport of Molecules between the Nucleus and the Cytosol
    Bidirectional traffic occurs continuously between the cytosol and the nucleus. The many proteins that function in the nucleus—including histones, DNA and ...
  48. [48]
    The essential kinase ATR: ensuring faithful duplication of a ... - NIH
    One crucial function of the ATR pathway is to arrest the cell cycle following DNA damage in S phase. This arrest is initiated by the phosphorylation of CHK1 by ...
  49. [49]
    Understanding the interplay between dNTP metabolism and ...
    Aug 29, 2024 · Summary: This Review provides an overview of the current knowledge on both the causes and consequences of dNTP pool perturbations in cancer ...Causes Of Dntp Pool... · Perturbation Of Dntp... · Consequences Of Dntp Pool...
  50. [50]
    Nucleotide imbalance decouples cell growth from cell proliferation
    Aug 4, 2022 · Further, RNR mutations that lead to depletion of specific dNTPs can slow S phase progression in budding yeast, underscoring the importance of ...
  51. [51]
    Mitochondrial Thymidine Kinase and the Enzymatic Network ...
    Catabolic enzymes safeguard the size of the dTTP pool: thymidine phosphorylase by degradation of thymidine and deoxyribonucleotidases by degradation of dTMP.
  52. [52]
    The deoxynucleotide triphosphohydrolase SAMHD1 is a major ...
    SAMHD1 is clearly a major regulator of dNTP pool turnover, whose loss has large effects on the composition of the cellular dNTP pool both during quiescence and ...
  53. [53]
    DPYS - Dihydropyrimidinase - Homo sapiens (Human) | UniProtKB
    Catalyzes the second step of the reductive pyrimidine degradation, the reversible hydrolytic ring opening of dihydropyrimidines.<|separator|>
  54. [54]
    Regulation of deoxynucleotide metabolism in cancer - NIH
    Sep 29, 2015 · Regulation of intracellular deoxynucleoside triphosphate (dNTP) pool is critical to genomic stability and cancer development.
  55. [55]
    Dynamics of the dATP pool in cultured mammalian cells - PubMed
    In S-phase cells the dATP pool had a half-life of 4 min, identical to that of dTTP determined earlier. Deoxyadenosine was the major breakdown product of dATP ...
  56. [56]
    Mitochondrial DNA Depletion and Thymidine Phosphate Pool ...
    With thymidine in the medium, the dTTP pool of quiescent cells turned over rapidly at a rate depending on the concentration of thymidine, due to increased ...
  57. [57]
    Deoxyribonucleotide Metabolism in Cycling and Resting Human ...
    In earlier experiments we found that during quiescence normal human fibroblasts maintained a low level of ribonucleotide reduction, as determined in situ from ...
  58. [58]
    Inhibition of dUTPase Induces Synthetic Lethality with Thymidylate ...
    Inhibition of TS depletes thymidylate pools, inducing a thymineless state and growth arrest (4–6). Two classes of therapeutic agents that target thymidylate ...
  59. [59]
    Molecular Basis of Drug Interactions of Methotrexate ...
    Feb 19, 2015 · DHFR inhibition by MTX results in reduced folate pool. Reduced ... Depletion of dTMP results in the depletion of deoxythymidine triphosphate (dTTP) ...Introduction · Methotrexate · P53 Dependent Pathway
  60. [60]
    Zidovudine: Uses, Interactions, Mechanism of Action - DrugBank
    It inhibits the activity of HIV-1 reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleotide analogue. It competes with the ...Interactions · Spectra · Transporters
  61. [61]
    Nucleotide Reverse Transcriptase Inhibitors: A Thorough Review ...
    May 13, 2020 · NRTIs are a class of drugs that inhibit the HIV-1 RT enzyme by competing with natural nucleosides (such as dTTP, dCTP, dGTP and dATP) and act by ...
  62. [62]
    Thymidine Kinase 2 Deficiency - Symptoms, Causes, Treatment
    Mar 4, 2025 · A rare genetic disorder that mainly affects the muscles. The signs and symptoms may include muscle weakness of some degree.Missing: immunodeficiency | Show results with:immunodeficiency
  63. [63]
    World Academy of Sciences Journal - Spandidos Publications
    Mar 5, 2025 · Lesch‑Nyhan Syndrome (LNS) is a rare inborn error of metabolism caused by a deficiency in the hypoxanthine‑guanine phosphoribosyl ...Missing: dTTP | Show results with:dTTP
  64. [64]
    Deoxyribonucleoside Triphosphate Accumulation by Leukemic Cells
    Aug 1, 1983 · Closed circles (•) represent dATP levels greater than 200 pmole/106 cells. NMC, normal mononuclear cells; ALL. acute lymphoblastic leukemia; CLL ...
  65. [65]
    Re-Discovery of Pyrimidine Salvage as Target in Cancer Therapy
    Here we discuss the re-discovery of targeting pyrimidine salvage pathways for DNA replication alone or in combination with inhibitors of pyrimidine de novo ...2. Pyrimidine De Novo And... · 4. Pyrimidine Salvage As... · 4.3. Thymidine Kinases As A...
  66. [66]
    Modulating CRISPR/Cas9 genome-editing activity by small molecules
    Azidothymidine (AZT), a thymidine analog, was identified by cell-based screening platforms and thought to significantly increase CRISPR/Cas9-mediated gene ...
  67. [67]
    Isocratic HPLC analysis for the simultaneous determination of ...
    The levels of dNTPs vary between different species, cell types, and growth phases, but in mammalian cells they are typically 2–3 orders of magnitude lower than ...Materials And Methods · Final Hplc Protocols · Results
  68. [68]
    A LC-MS/MS Method for the Analysis of Intracellular Nucleoside ...
    This method provides a practical tool to measure intracellular dNTP/NTP levels in cells and clinical samples.Missing: prognosis | Show results with:prognosis
  69. [69]
    Regulation of deoxynucleotide metabolism in cancer
    Sep 29, 2015 · Regulation of intracellular deoxynucleoside triphosphate (dNTP) pool is critical to genomic stability and cancer development.
  70. [70]
    [PDF] pcr-master-mix-protocol.pdf - Promega Corporation
    PCR Master Mix is a premixed, ready-to-use solution containing Taq DNA polymerase, dNTPs, MgCl2 and reaction buffers at optimal concentrations for efficient ...
  71. [71]
    DNA sequencing using biotinylated dideoxynucleotides and mass ...
    We report here the development of a novel MS DNA sequencing method that generates Sanger-sequencing fragments in one tube using biotinylated dideoxynucleotides.
  72. [72]
    DNA Ligase I Selectively Affects DNA Synthesis by DNA ...
    Jun 5, 1998 · Then dCTP, dGTP, and dTTP (30 μm each) and DNA ligase I (in amounts as described in the figure legend) were added. DNA synthesis was allowed ...
  73. [73]
  74. [74]
    DNA Sequencing Methods: From Past to Present - PMC - NIH
    Since each base corresponds to a different ddNTP reaction, the Sanger method of DNA sequencing creates a total of 4 distinct reactions for each base (Figure 1B) ...